OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Chair received an award of 100K GMED derivative securities | OQRO

Home
Insider trades
Globus Medical
Chair received an award of 100K GMED derivative securities

Insider trades

Insider trade

Chair received an award of 100K GMED derivative securities

Traded Jan 21, 2026 · Filed Jan 23, 2026

GMEGlobus MedicalGMED

100K
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jan 21, 2026
Reporting period: Not applicable
Filed with the SEC: Jan 23, 2026

ChairGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193125-26-021239
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Jan 23, 2026, 10:03 PM UTC

Added to OQRO

Oct 6, 2026, 7:37 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GLOBUS MEDICAL INC

Issuer CIK

1237831

Ticker

GMED

Reporting person

David C Paul

Relationship

Director, Officer, 10% owner

Officer title

Executive Chairman

Security

Stock Option (Right to Buy Class A Common Stock)

Table

Derivative (Table II)

Transaction date

Jan 21, 2026

Transaction code

Shares / units

100,000

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

100,000

Ownership form

Direct

Amendment

Footnotes from the filing

These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter.

Around the same time

Kelly HullerEVP, GC, Corporate Secretary

Filed 8mo ago

10KShares · @ $45.64

Traded Feb 12 · filed 5 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Kelly Huller (EVP, GC, Corporate Secretary) sold ~$877K of Globus Medical

Scheduled in advanceFiled 8mo ago

Kelly HullerEVP, GC, Corporate Secretary

Filed 8mo ago

10KDerivative units

Traded Feb 12 · filed 5 days later

Derivative exercise or conversion — not an open-market buy.

More Official record